A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
University of Chicago
BeOne Medicines
Eli Lilly and Company
Gilead Sciences
H. Lee Moffitt Cancer Center and Research Institute
Universität des Saarlandes
Incyte Corporation
Celgene
Masonic Cancer Center, University of Minnesota
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Oncternal Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
AstraZeneca
BeiGene
BeiGene
Stanford University
University of Rochester
City of Hope Medical Center
University of Colorado, Denver
City of Hope Medical Center
Eastern Cooperative Oncology Group
City of Hope Medical Center
Mayo Clinic
University of Nebraska
University of Nebraska
OHSU Knight Cancer Institute
Ipsen
TG Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Massachusetts General Hospital
Atara Biotherapeutics
Brown University
International Extranodal Lymphoma Study Group (IELSG)
Mayo Clinic
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
Gilead Sciences
Novartis
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)